Author: OurCrowd

[ReWalk in Simply Wall St] ReWalk Robotics (NASDAQ:RWLK) Is In A Good Position To Deliver On Growth Plans

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. Read more...

Read More

[DouxMatok in Yahoo! Finance] Blommer Chocolate Company and DouxMatok Expand Partnership with New Chocolate and Confectionery Coatings

NEW YORK, May 11, 2022–(BUSINESS WIRE)–Today Blommer Chocolate Company (USA), the largest cocoa processor and ingredient chocolate supplier in North America, and DouxMatok (Israel/USA), a food tech company spearheading sugar reduction, announced the launch of additional chocolate and confectionery products. Earlier this year, Blommer launched the innovative Discovery product line, empowered by DouxMatok’s award-winning sugar-based sugar reduction solution, Incredo® Sugar. The first products were chocolate-flavored chips and they have now expanded the product line to include additional coatings to support utilization in a broader range of food applications, including but not limited to panning, enrobing, and molding. Read...

Read More

[BOL Pharma in Outsourced Pharma] Kindeva And BOL Pharma Using Low Global Warming Potential (GWP) Propellant In Development Of Inhaled Cannabinoid Products

St. Paul, MN — Kindeva Drug Delivery (Kindeva) and Breath of Life International (BOL Pharma or BOL) have agreed to the use of low GWP propellants in multiple inhaled cannabinoid products. Kindeva will develop novel formulations of BOL Pharma’s cannabinoid-based drug products delivered by Kindeva’s pressurized metered-dose inhaler (pMDI) technology using the next generation of low GWP propellants. Subject to all required regulatory approvals, the products under development are targeted to treat chronic neuropathic pain. If successful, this early-stage activity could lead to the long-term commercial supply of regulated inhaled cannabinoid products using low GWP propellants, leveraging Kindeva’s commercial manufacturing capabilities and BOL’s accumulated know-how and innovation in the field of medical cannabis. Read...

Read More